Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 74,062

Document Document Title
WO/2016/200614A3
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.  
WO/2016/197561A1
Provided are a methionine lyase and an encoding gene thereof, wherein the gene is isolated from Tuber melanosporum and the nucleotide sequence thereof is as shown in SEQ ID No. 1. Further provided is a method for efficiently biosynthesiz...  
WO/2016/198852A1
The invention relates to a genetically transformed or transfected bacterial cell of a gut symbiont of an insect belonging to the Order Thysanoptera wherein said cell is transformed to express double-stranded RNA (dsRNA) active against at...  
WO/2016/200614A2
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.  
WO/2016/191828A1
The present invention relates to microbial inoculants, fertiliser compositions, growth mediums and methods for enhancing plant growth. In one aspect, the invention relates to a method of increasing plant growth, plant productivity, seed ...  
WO/2016/192871A1
The invention relates to mutant bacteria of the genus Clostridium beijerinckii, CNCM I-4985, CNCM I-4986, CNCM I-4987 and CNCM I-4988, deposited on the 27th May 2015 at the Pasteur institute (CNCM, 25 rue du Docteur Roux, F-75724 PARIS C...  
WO/2016/193896A1
The present invention provides for identifying and detecting clinically and economically important Brucella species and their biovars. More specifically the invention provides for novel primers for identifying and detecting clinically an...  
WO/2016/191839A1
The present invention relates to a method for obtaining outer membrane vesicles (OMV) by biofermentation from the Haemophilus aegyptius 254 (Hae254) line, thus obtained outer membrane vesicles (OMV-Hae254), and use thereof to facilitate ...  
WO/2016/196654A1
Transgenic plant species engineered to inhibit aflatoxin production in Aspergillus species, methods of producing such transgenic plant species that can inhibit aflatoxin production, and compositions for such transgenic plant production. ...  
WO/2016/189067A1
The present invention relates to an attenuated Piscirickettsia salmonis bacterium. The bacterium comprises mutations in the amino acid sequence of each of the rpoD, FecR, ATP-grasp domain protein, and FtsH gene products. The invention al...  
WO/2016/190513A1
The present invention relates to a novel indigenous natural lactobacillus, Lactobacillus brevis SPC-SNU 70-2 (KCTC 12777BP), isolated from traditional Korean malt.  
WO/2016/190512A1
The present invention relates to a novel indigenous natural lactobacillus, Lactobacillus curvatus SPC-SNU 70-3 (KCTC 12778BP), isolated from traditional Korean malt.  
WO/2016/187908A1
The present invention provides a novel recombinant oncolytic adenovirus and an application thereof. The recombinant oncolytic adenovirus has dual specificity; namely, tumor-specific replication and tumor-specific killing, can replicate i...  
WO/2016/190514A1
The present invention relates to a novel indigenous natural lactobacillus, Lactobacillus sanfranciscensis SPC-SNU 70-4 (KCTC 12779BP), isolated from traditional Korean malt.  
WO/2016/184044A1
Disclosed are very high optically pure D- and L- lactic acid fermentation production strains and construction methods thereof and the method for preparing very high optically pure D- and L- lactic acids using the strains, wherein the dep...  
WO/2016/187021A1
The present invention is directed to methods for making fermented beverages and other fermentation products including lactic acid and ethanol for fuel and the products produced therefrom.  
WO/2016/184663A1
The present invention relates to a microbial cell capable of producing at least one acetylhomoserine from 4-acetyl-butyric acid and/or ester thereof, wherein the cell is genetically modified to comprise -at least a first genetic mutation...  
WO/2016/180037A1
Provided are LAMP primers for detecting the respiratory tract infection pathogen(s), and kits, chips and systems comprising the LAMP primers. Also provided is a method of detecting a pathogen (e.g., a respiratory tract infection pathogen...  
WO/2016/183413A1
The present disclosure provides compositions and methods for making and using methanotrophic proline auxotrophs.  
WO/2016/179639A1
The present invention relates to a probiotic composition comprising: coconut milk; bacteria capable of fermenting saccharides to lactic acid; and saccharides, wherein the saccharides are supplementary to any present in the coconut milk, ...  
WO/2016/180300A1
Provided is amino acid optimization of a functional motif on IrrE protein of a deinococcus strain and a homologous protein thereof by using a manner of site mutation, in which second-site or fifth-site alanine in a functional domain moti...  
WO/2016/179735A1
Provided is a method of semi-solid state fermentation for producing surfactin from a mutant strain of Bacillus subtilis subsp. Physical or chemical mutation is conducted on Bacillus subtilis subsp. isolated from Thailand seawater shrimp ...  
WO/2016/183163A1
Methods and materials for genetically engineering methylotrophic yeast are provided.  
WO/2016/176729A1
The present invention relates to novel bacteriocins with a wide antimicrobial activity against bacteria, including food spoilage and pathogenic bacteria, and the genes that encode said bacteriocins. In particular, the present invention r...  
WO/2016/178773A1
The invention generally relates to disease detection and medical diagnosis. More particularly, the invention relates to novel systems and methods for detecting Clostridium difficile toxins and related diseases and disorders. In one aspec...  
WO/2016/178493A1
The present invention relates to tyndallized Clostridium butyricum having an effect of preventing and treating arthritis, and a use thereof and, more specifically, to: dead bacterial cells of tyndallized Clostridium butyricum IDCC 5101 c...  
WO/2016/178039A1
The invention is a method for the use of a microorganism preparation, preferably a yeast cell preparation, in an assay for the quantitative measurement of the biochemical function of animal cells assayed in an in vitro assay, for the qua...  
WO/2016/175565A1
The present invention relates to a medium composition for production of botulinum toxin and, more particularly, to a medium composition for culture of Clostridium sp. capable of producing botulinum toxin. The medium composition of the pr...  
WO/2016/173556A1
A novel gene targeting method and a nucleotide construct for the method. The method integrates a nucleotide construct containing an interference gene in an effective gene targeting region independent of the gene by homologous recombinati...  
WO/2016/174349A1
The invention relates to a method for selecting a yeast strain having improved capability for fermenting a pentose, advantageously xylose, in the presence of organic acid, advantageously acetic acid, in non-dissociated form, in which at ...  
WO/2016/174226A1
The present invention relates to compounds of general formula (I), wherein R1-R8 take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prophylaxis of cancer.  
WO/2016/173083A1
Provided is a process for recovering CO2-containing exhaust gas to prepare an oil product and a combustion gas, which comprises the following steps: (1) mixing the CO2-containing exhaust gas with an alkaline solution to obtain a mixed so...  
WO/2016/176164A1
Methods, pharmaceutical compositions and vaccines comprising an attenuated bacteria that expresses a recall antigen are disclosed for treatment of cancer.  
WO/2016/172438A1
Microorganisms with increased photosynthetic capacity are described. Increased photosynthetic capacity is achieved by down-regulating activity of the RpaB pathway. The microorganisms include Cyanobacteria, including genetically-modified ...  
WO/2016/169306A1
Provided are a method for improving the expression of lipase by glycosylation modification, mutant enzymes and an application of the mutant enzymes, specifically comprising: performing N-glycosylation mutation on a propeptide sequence of...  
WO/2016/170205A1
The invention relates to a method for the production of ethanol from a source of chitosan, comprising the use of Metarhizium anisopliae , and to the use of said fungi for the degradation of seafood waste, and producing fungal biomass for...  
WO/2016/170204A1
The invention relates to a method for producing ethanol from a source of chitosan, comprising the use of Pochonia chlamydosporia, and to the use of said fungus for the degradation of shellfish waste, also producing fungal biomass for the...  
WO/2016/170155A1
The invention relates to a method for obtaining a mutant oleaginous yeast strain capable of growing on cellobiose as carbon source, comprising overexpressing in said strain two β-glucosidase enzymes further comprising a N-terminal signa...  
WO/2016/170206A1
The invention relates to a method for producing ethanol from a chitosan source, comprising the use of at least one of the following fungi: Beauveria bassiana. The invention also relates to the use of said fungus for the degradation of sh...  
WO/2016/169061A1
A microalgae culture photobioreactor comprises a reactor outer cylinder (1), a reactor inner cylinder (2), a vent tube (3) and a drive device (4). The reactor outer cylinder (1) and the reactor inner cylinder (2) are vertically disposed,...  
WO/2016/165037A1
The present invention provides a nematicidal composition and a method that uses said composition to control nematode pathogens present in plants. The composition comprises the rhizobacteria Brevibacterium frigoritolerans and Bacillus wei...  
WO/2016/168709A1
In some aspects, the disclosure relates to methods and compositions for delivery of proteins into mammalian cells. In some embodiments, the disclosure provides a genetically engineered bacterium that may be useful for delivery of protein...  
WO/2016/168413A1
Disclosed are whole-cell catalysts, methods of making the whole-cell catalysts, and methods of using the whole-cell catalysts to produce steviol glycosides.  
WO/2016/167489A1
The present invention relates to a novel Lactobacillus sp. isolation strain having an ability to inhibit the proliferation of vaginitis pathogens, and a pharmaceutical composition, a health functional food, and a cleaning product, which ...  
WO/2016/162661A1
Aspects of the present invention relate to a method and an apparatus for treating oil sands process water (OSPW). More particularly, aspects of the invention relate to a method of treating OSPW using a microorganism capable of metabolizi...  
WO/2016/164502A1
Disclosed herein are non-myeloablative antibody-toxin conjugates and compositions that target cell surface markers, such as the CD34, CD45 or CD117 receptors, and related methods of their use to effectively conditioning a subject's tissu...  
WO/2016/163534A1
A sporulation method of a Bacillus bacterium that comprises a step for culturing the Bacillus bacterium using a liquid medium having a C/N ratio (the weight ratio of carbon content to nitrogen content) of 4-9.5 exclusive.  
WO/2016/155567A1
Provided are a Streptomyces (Streptomyces hygroscopicus) HS7522 and a method for preparing milbemycin A4 by culturing the Streptomyces. The Streptomyces (Streptomyces hygroscopicus) HS7522 of the present invention is deposited in "China ...  
WO/2016/156260A1
The invention relates to the use of a yeast strain overexpressing at least the following genes: the ALK3 gene, at least one of genes ADH2 and ADH5 and at least one of genes FALDH3 and FALDH4, or gene FA01, for the fermentation-based prod...  
WO/2016/155568A1
Provided are a Streptomyces (Streptomyces hygroscopicus) HS7523 and a method for preparing milbemycin A3 by culturing the Streptomyces. The Streptomyces (Streptomyces hygroscopicus) HS7523 is deposited in "China General Microbiological C...  

Matches 651 - 700 out of 74,062